Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000549960 | SCV000640731 | pathogenic | Nemaline myopathy 2 | 2024-01-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro8025Serfs*154) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). This variant is present in population databases (rs756384471, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with NEB-related conditions. ClinVar contains an entry for this variant (Variation ID: 465574). For these reasons, this variant has been classified as Pathogenic. |
Counsyl | RCV000549960 | SCV000799414 | uncertain significance | Nemaline myopathy 2 | 2018-04-18 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003476279 | SCV004200069 | likely pathogenic | Arthrogryposis multiplex congenita 6 | 2024-03-26 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003488672 | SCV004238307 | likely pathogenic | not provided | 2023-05-24 | criteria provided, single submitter | clinical testing | |
Center of Excellence for Medical Genomics, |
RCV000549960 | SCV002546538 | pathogenic | Nemaline myopathy 2 | 2022-09-08 | no assertion criteria provided | research |